Table 2.
List of peptides identified from tumor-associated antigens
| Gene name (protein name) | Peptide sequence | FM-82 | FM-93/2 | Mel-624 | MeWo | SK-Mel-5 | HLA Alleles (IC50 in nM by NetMHCpan 2.8) |
|---|---|---|---|---|---|---|---|
| SEPT2 (septin-2) | KVNIVPVIAK | X | A*03:01 (46 nM) | ||||
| RLYPWGVVEV | X | X | X | A*02:01 (5 nM) | |||
| VEIEERGVKL | X | X | B*40:01 (47 nM) | ||||
| YIDEQFERY | X | A*01:01 (12 nM) | |||||
| ALDH1A1 (retinal dehydrogenase 1) | ASERGRLLY | X | A*01:01 (35 nM) | ||||
| TMESMNGGKLY | X | No binding predicted | |||||
| ARL4D (ADP-ribosylation factor-like protein 4D) | RLYEMILKR | X | A*03:01 (51 nM) | ||||
| ATIC (IMP cyclohydrolase) | NLYPFVKTV | X | X | A*02:01 (41 nM) | |||
| BCAP31 (B-cell receptor-associated protein 31) | KLDVGNAEV | X | X | X | X | X | A*02:01 (27 nM) |
| CCNB1 (G2/mitotic-specific cyclin-B1) | VMVNQGLTKHMTV | X | A*02:01 (93 nM) | ||||
| VVMVNQGLTK | X | X | A*11:01 (27 nM), A*03:01 (95 nM) | ||||
| GEVDVEQHTL | X | X | B*40:01 (10 nM) | ||||
| TLAKYLMEL | X | X | X | X | A*02:01 (7 nM) | ||
| CCND1 (G1/S-specific cyclin-D1) | ALLESSLRQA | X | X | X | A*02:01 (90 nM) | ||
| EVFPLAMNY | X | X | A*26:01 (22 nM) | ||||
| EVFPLAMNYL | X | A*26:01 (221 nM), C*12:03 (176 nM) | |||||
| CCNI (cyclin-I) | AVLTKQLLH | X | No binding predicted | ||||
| EVIQWLAKL | X | A*26:01 (11 nM) | |||||
| LLDRFLATV | X | X | X | X | A*02:01 (8 nM) | ||
| SLLDRFLATV | X | A*02:01 (4 nM) | |||||
| CDR2 (cerebellar degeneration-related protein 2) | NSELEQQLGATGAY | X | A*01:01 (67 nM) | ||||
| RELEETNQKL | X | X | B*40:01 (19 nM) | ||||
| CEP55 (centrosomal protein of 55 kDa) | AELESKTNTL | X | B*40:01 (34 nM) | ||||
| EVHNLNQLLY | X | X | A*26:01 (22 nM) | ||||
| CPSF1 (cleavage and polyadenylation specificity factor subunit 1) | ALDEKLLNI | X | A*02:01 (47 nM) | ||||
| RLGNSLLLK | X | A*03:01 (17 nM) | |||||
| TLITDGMRSV | X | X | A*02:01 (76 nM) | ||||
| VSDRDRNLMVY | X | A*01:01 (13 nM) | |||||
| CSPG4 (chondroitin sulfate proteoglycan 4) | ALTDIDLQL | X | A*02:01 (62 nM) | ||||
| ASSSAGTDPQLLLY | X | A*01:01 (39 nM) | |||||
| SSSAGTDPQLLLY | X | A*01:01 (14 nM) | |||||
| STDPQHHAY | X | A*01:01 (5 nM) | |||||
| TMLARLASA | X | X | X | A*02:01 (44 nM), B*08:01 (40 nM) | |||
| TPNPALKNGQYW | X | No binding predicted | |||||
| DCT (l-dopachrome tautomerase) | ELAPIGHNRMY | X | A*26:01 (50 nM) | ||||
| ETHLSSKRY | X | X | A*26:01 (207 nM) | ||||
| GTYEGLLRR | X | X | A*03:01 (421 nM), A*11:01 (56 nM) | ||||
| KELPSLHVL | X | B*40:01 (18 nM) | |||||
| LMETHLSSK | X | A*03:01 (122 nM) | |||||
| MTVDSLVNK | X | A*11:01 (9 nM) | |||||
| REQFLGALDL | X | X | B*40:01 (13 nM) | ||||
| SLDDYNHLV | X | A*02:01 (4 nM) | |||||
| SLDDYNHLVTL | X | X | X | A*02:01 (10 nM) | |||
| TRPWSGPYIL | X | C*07:02 (182 nM) | |||||
| TSDQLGYSY | X | A*01:01 (8 nM) | |||||
| VEETPGWPTTL | X | X | B*40:01 (61 nM) | ||||
| YYSVRDTLL | X | C*07:02 (57 nM) | |||||
| EHD2 (EH domain-containing protein 2) | ALASHLIEA | X | X | X | A*02:01 (6 nM) | ||
| GQYSTGKTSFIQY | X | B*15:01 (40 nM) | |||||
| KLPNSVLGR | X | No binding predicted | |||||
| RVHAYIISY | X | A*03:01 (59 nM) | |||||
| ENAH (protein enabled homolog) | ERLERQERL | X | No binding predicted | ||||
| GAGE12I (G antigen 12I) | YYWPRPRRY | X | No binding predicted | ||||
| GPR143 (G-protein-coupled receptor 143) | ATSPPASVR | X | X | A*11:01 (103 nM) | |||
| AVASLLKGR | X | No binding predicted | |||||
| GLSTILLYH | X | A*03:01 (390 nM) | |||||
| HAIPHYVTM | X | X | X | C*03:03 (5 nM), C*03:04 (5 nM) | |||
| MLYYPSVSR | X | A*03:01 (29 nM) | |||||
| HMMR (hyaluronan mediated motility receptor) | KLLEYIEEI | X | X | A*02:01 (2 nM) | |||
| KLQEELNKV | X | X | A*02:01 (12 nM) | ||||
| RLNAALREK | X | A*03:01 (62 nM) | |||||
| HMOX1 (heme oxygenase 1) | EVIPYTPAM | X | X | A*26:01 (5 nM) | |||
| EVIPYTPAMQR | X | No binding predicted | |||||
| EVIPYTPAMQRY | X | A*26:01 (4 nM) | |||||
| HNRNPL (heterogeneous nuclear ribonucleoprotein L) | AAAGGGGGGGRY | X | X | No binding predicted | |||
| AAAGGGGGGGRYY | X | B*15:01 (159 nM) | |||||
| ETLGFLNHY | X | A*26:01 (14 nM) | |||||
| KQPAIMPGQSY | X | B*15:01 (98 nM) | |||||
| KSDALETLGFLNHY | X | No binding predicted | |||||
| MAAAGGGGGGGRY | X | X | X | A*26:01 (170 nM), B*15:01 (59 nM) | |||
| YAVDRAITH | X | X | C*12:03 (59 nM), C*03:04 (273 nM) | ||||
| HSPA1L (heat-shock 70 kDa protein 1-like) | LIFDLGGGTFD | X | No binding predicted | ||||
| TVFDAKRLIGR | X | X | A*11:01 (109 nM) | ||||
| DTERLIGDAAKNQV | X | No binding predicted | |||||
| RLIGDAAKNQV | X | X | X | X | X | A*02:01 (84 nM) | |
| AMTKDNNLL | X | X | No binding predicted | ||||
| IGF2BP3 (insulin-like growth factor 2 mRNA-binding protein 3) | EVLDSLLVQY | X | A*26:01 (47 nM) | ||||
| KIQEILTQV | X | X | X | X | A*02:01 (21 nM) | ||
| TLYNPERTITV | X | X | A*02:01 (80 nM) | ||||
| IL13RA2 (interleukin-13 receptor subunit alpha-2) | LLDTNYNLF | X | No binding predicted | ||||
| LLDTNYNLFY | X | A*01:01 (10 nM) | |||||
| KDM5B (lysine-specific demethylase 5B) | ALKDSVQRA | X | X | No binding predicted | |||
| RLIDLGVGL | X | A*02:01 (20 nM) | |||||
| RQFVTQLY | X | B*15:01 (30 nM) | |||||
| SVAQQLLNGK | X | A*03:01 (20 nM) | |||||
| KIF20A (kinesin-like protein KIF20A) | KEAGNINTSL | X | B*40:01 (14 nM) | ||||
| RVFQGFFTGR | X | X | A*11:01 (22 nM), A*03:01 (72 nM) | ||||
| SEHLDTQKELL | X | B*40:01 (80 nM) | |||||
| LGALS3BP (galectin-3-binding protein) | ALWKEPGSNV | X | A*02:01 (42 nM) | ||||
| NLWDLTDASVV | X | A*02:01 (19 nM) | |||||
| RIDITLSSV | X | A*02:01 (179 nM) | |||||
| MAGEA1 (melanoma-associated antigen 1) | ALREEEEGV | X | No binding predicted | ||||
| EADPTGHSY | X | A*01:01 (79 nM) | |||||
| EVYDGREHSA | X | No binding predicted | |||||
| KEADPTGHSY | X | No binding predicted | |||||
| KVLEYVIKV | X | A*02:01 (5 nM) | |||||
| LTQDLVQEKYLEY | X | A*01:01 (42 nM) | |||||
| SAYGEPRKL | X | C*03:04 (184 nM) | |||||
| MAGEA12 (melanoma-associated antigen 12) | EVVRIGHLY | X | A*26:01 (7 nM) | ||||
| KMAELVHFL | X | X | X | A*02:01 (2 nM) | |||
| MAGEA12; MAGEA6; MAGEA3 (melanoma-associated antigen 12; 6; 3) | KIWEELSVLE | X | No binding predicted | ||||
| MAGEA2 (melanoma-associated antigen 2) | EVFEGREDSVF | X | X | A*26:01 (72 nM) | |||
| MAGEA2; MAGEA2B (melanoma-associated antigen 2; 2B) | KMVELVHFL | X | A*02:01 (2 nM) | ||||
| MAGEA1; MAGEA2; MAGEA2B; MAGEA3; MAGEA6 (melanoma-associated antigen 1; 2; 2B; 3; 6) | REPVTKAEML | X | B*40:01 (255 nM) | ||||
| MAGEA3 (melanoma-associated antigen 3) | EVDPIGHLYIF | X | No binding predicted | ||||
| MAGEA4 (melanoma-associated antigen 4) | GVYDGREHTV | X | A*02:01 (225 nM) | ||||
| MAGEA4; MAGEA8 (melanoma-associated antigen 4; 8) | KVLEHVVRV | X | A*02:01 (9 nM) | ||||
| MAGEA3; MAGE6 (melanoma-associated antigen 3; 6) | KIWEELSVLEV | X | X | A*02:01 (7 nM) | |||
| MAGEC2 (melanoma-associated antigen C2) | ALIEVGPDHFC | X | No binding predicted | ||||
| MDM2 (E3 ubiquitin–protein ligase Mdm2) | RLYDEKQQHI | X | A*02:01 (72 nM) | ||||
| RLYDEKQQHIVY | X | B*15:01 (54 nM) | |||||
| MET (hepatocyte growth factor receptor) | EVIGRGHFGCVY | X | A*26:01 (6 nM) | ||||
| KSEMNVNMKY | X | A*01:01 (193 nM) | |||||
| MFGE8 (lactadherin) | EVRGDVFPSY | X | A*26:01 (15 nM) | ||||
| MLANA (melanoma antigen recognized by T cells 1) | AEEAAGIGIL | X | B*40:01 (9 nM) | ||||
| ALMDKSLHV | X | A*02:01 (4 nM) | |||||
| MMP2 (72 kDa type IV collagenase; PEX) | AVVDLQGGGHSY | X | X | A*26:01 (232 nM) | |||
| NELFA (negative elongation factor A) | KLLDISELDMV | X | X | X | A*02:01 (4 nM) | ||
| NOB1 (RNA-binding protein NOB1) | ALQDIGKNIYTI | X | A*02:01 (59 nM) | ||||
| NPM1 (nucleophosmin) | DIKAKMQAS | X | No binding predicted | ||||
| FEITPPVVL | X | X | B*40:01 (10 nM) | ||||
| KMQASIEKA | X | X | A*02:01 (472 nM) | ||||
| RMTDQEAIQ | X | X | No binding predicted | ||||
| RMTDQEAIQDL | X | X | X | X | A*02:01 (347 nM) | ||
| YEGSPIKVTL | X | X | B*40:01 (24 nM) | ||||
| NUDCD1 (NudC domain-containing protein 1) | AEEHSIATL | X | B*40:01 (13 nM) | ||||
| NUF2 (kinetochore protein Nuf2) | ATAQFKINK | X | A*11:01 (11 nM) | ||||
| EVVEKYEIY | X | A*26:01 (9 nM) | |||||
| KIDEKTAELK | X | No binding predicted | |||||
| OCA2 (P protein) | HVDSTLLQ | X | No binding predicted | ||||
| HVDSTLLQV | X | X | X | X | A*02:01 (170 nM) | ||
| KEPSEIVEL | X | B*40:01 (104 nM) | |||||
| PASD1 (PAS domain-containing protein 1) | QLEERTWLL | X | A*02:01 (79 nM) | ||||
| PGK1 (phosphoglycerate kinase 1) | DNGAKSVVL | X | No binding predicted | ||||
| EGKVLPGVDALSNI | X | No binding predicted | |||||
| PLIN2 (perilipin-2) | RAYQQALSR | X | A*03:01 (140 nM) | ||||
| SLLTSSKGQLQK | X | A*03:01 (53 nM) | |||||
| SVASTITGV | X | A*02:01 (55 nM) | |||||
| TLLSNIQGV | X | A*02:01 (9 nM) | |||||
| TSALPIIQK | X | A*11:01 (24 nM) | |||||
| PMEL (melanocyte protein PMEL; M-alpha; M-beta) | ALDGGNKHFL | X | X | X | X | X | A*02:01 (168 nM) |
| ALLAVGATK | X | A*03:01 (45 nM) | |||||
| ALNFPGSQK | X | A*03:01 (21 nM) | |||||
| AMLGTHTMEV | X | X | X | X | X | A*02:01 (8 nM) | |
| AMLGTHTMEVTV | X | X | A*02:01 (20 nM) | ||||
| ASLIYRRRLMK | X | A*11:01 (61 nM) | |||||
| FALQLHDPSGY | X | C*03:04 (250 nM) | |||||
| FTITDQVPFSVSVSQLR | X | No binding predicted | |||||
| GTATLRLVK | X | X | A*11:01 (22 nM), A*03:01 (121 nM) | ||||
| HQILKGGSGTY | X | B*15:01 (25 nM) | |||||
| HSSSHWLRLP | X | X | No binding predicted | ||||
| HTYLEPGPVTAQ | X | No binding predicted | |||||
| ITDQVPFSV | X | C*05:01 (37 nM), A*02:01 (188 nM) | |||||
| ITDQVPFSVSVSQLR | X | No binding predicted | |||||
| KQDFSVPQL | X | A*02:01 (455 nM) | |||||
| KTWDQVPFS | X | No binding predicted | |||||
| KTWDQVPFSV | X | X | X | X | X | A*02:01 (11 nM) | |
| KTWDQVPFSVSV | X | A*02:01 (13 nM) | |||||
| KTWGQYWQ | X | No binding predicted | |||||
| KTWGQYWQV | X | X | X | X | X | A*02:01 (10 nM) | |
| LSIGTGRAM | X | X | C*03:03 (39 nM), C*03:04 (39 nM) | ||||
| LVLKRCLLH | X | No binding predicted | |||||
| MLGTHTMEV | X | X | X | X | A*02:01 (8 nM) | ||
| RNQPLTFALQLHDPSGY | X | No binding predicted | |||||
| RYGSFSVTL | X | C*07:02 (362 nM) | |||||
| SLADTNSLAV | X | A*02:01 (13 nM) | |||||
| SLADTNSLAVV | X | X | X | X | X | A*02:01 (12 nM) | |
| SVPQLPHSSSHW | X | No binding predicted | |||||
| TITDQVPFSVSVSQLR | X | No binding predicted | |||||
| VLYRYGSFSV | X | X | A*02:01 (6 nM) | ||||
| VLYRYGSFSVTL | X | A*02:01 (41 nM) | |||||
| YRYGSFSVTL | X | X | C*07:01 (10 nM), C*03:03 126 (nM) | ||||
| PPIB (peptidyl-prolyl cis–trans isomerase B) | LLLPGPSAA | X | X | X | X | A*02:01 (75 nM) | |
| PRAME (MELANOMA antigen preferentially expressed in tumors) | AAFDGRHSQTL | X | X | X | X | C*03:03 (7 nM), C*03:04 (7 nM), C*12:03 (16 nM) | |
| ALLERASATL | X | A*02:01 (25 nM) | |||||
| ALLPSLSHC | X | X | No binding predicted | ||||
| GQHLHLETF | X | B*15:01 (96 nM) | |||||
| QLLALLPSL | X | A*02:01 (9 nM) | |||||
| RLDQLLRHV | X | X | X | X | A*02:01 (217 nM) | ||
| RLVELAGQSLLK | X | A*03:01 (35 nM) | |||||
| SLLQHLIGL | X | X | A*02:01 (12 nM) | ||||
| YEDIHGTLHL | X | B*40:01 (15 nM) | |||||
| PRDX5 (peroxiredoxin-5, mitochondrial) | LLDDSLVSI | X | A*02:01 (8 nM) | ||||
| RAN (GTP-binding nuclear protein Ran) | AQYEHDLEVA | X | A*02:01 (303 nM) | ||||
| KLIGDPNLEFV | X | X | A*02:01 (5 nM) | ||||
| RHOC (Rho-related GTP-binding protein RhoC) | FSIDSPDSL | X | C*03:04 (6 nM) | ||||
| IEVDGKQVEL | X | X | B*40:01 (29 nM) | ||||
| RPA1 (replication protein A 70 kDa DNA-binding subunit) | DTEFPNFKY | X | A*01:01 (410 nM) | ||||
| EVFQNANFRSF | X | A*26:01 (43 nM) | |||||
| GAIAAIMQK | X | A*11:01 (32 nM) | |||||
| KAYGASKTFGK | X | X | A*03:01 (32 nM), A*11:01 (35 nM) | ||||
| KVIDQQNGL | X | No binding predicted | |||||
| SGMGSTVSK | X | A*11:01 (31 nM) | |||||
| VSDFGGRSL | X | X | X | X | X | C*03:03 (438 nM), C*03:04 (438 nM), C*05:01 (89 nM) | |
| RPL10A (replication protein A 70 kDa DNA-binding subunit) | FLASESLIKQI | X | X | X | X | A*02:01 (22 nM) | |
| NMVAKVDEV | X | X | X | X | A*02:01 (51 nM) | ||
| RILGPGLNK | X | A*03:01 (21 nM) | |||||
| SLIKQIPRI | X | X | X | A*02:01 (36 nM) | |||
| STIKFQMKK | X | A*11:01 (5 nM) | |||||
| TLYEAVREV | X | X | A*02:01 (9 nM) | ||||
| RPL19 (60S ribosomal protein L19) | HMYHSLYLK | X | A*03:01 (7 nM) | ||||
| ILMEHIHKL | X | X | X | X | X | A*02:01 (2 nM) | |
| ILMEHIHKLK | X | A*03:01 37 (nM) | |||||
| ILMEHIHKLKA | X | A*02:01 (19 nM) | |||||
| KLIKDGLIIRK | X | A*03:01 (49 nM) | |||||
| RILMEHIHKLK | X | A*03:01 (90 nM) | |||||
| RLASSVLRCGK | X | A*03:01 (23 nM) | |||||
| WLDPNETNEI | X | A*02:01 (79 nM) | |||||
| RPS2 (40S ribosomal protein S2) | KEWMPVTKL | X | B*40:01 (28 nM) | ||||
| RPSA (40S ribosomal protein SA) | NTDSPLRY | X | A*01:01 (7 nM) | ||||
| SART1 (U4/U6.U5 tri-snRNP-associated protein 1) | GLLETTVQKV | X | X | A*02:01 (9 nM) | |||
| KSMNANTITK | X | X | A*03:01 (61 nM), A*11:01 (12 nM) | ||||
| RVKAPNKSL | X | No binding predicted | |||||
| SFMBT1 (Scm-like with four MBT domains protein 1) | ESVMINGKY | X | A*26:01 (41 nM) | ||||
| SSDNYEHWLY | X | A*01:01 (5 nM) | |||||
| SH3GLB2 (endophilin-B2) | EVAPPASGTR | X | No binding predicted | ||||
| SOX10 (transcription factor SOX-10) | ETAGPQGPPHY | X | X | A*26:01 (13 nM) | |||
| EVMSNMETF | X | A*26:01 (14 nM) | |||||
| FSYMGPSQRPL | X | X | X | C*03:03 (3 nM), C*03:04 (3 nM) | |||
| GTAAIQAHY | X | X | No binding predicted | ||||
| ISKPPGVAL | X | X | C*03:04 (228 nM), C*12:03 (152 nM) | ||||
| YGHSGQASGLY | X | No binding predicted | |||||
| YSDHQPSGPYY | X | A*01:01 (5 nM) | |||||
| YTDQPSTSQIAY | X | A*01:01 (4 nM) | |||||
| KLADQYPHL | X | X | A*02:01 (6 nM) | ||||
| KTLGKLWRL | X | X | X | A*02:01 (74 nM) | |||
| STAT1 (signal transducer and activator of transcription 1-alpha/beta) | ALLKDQQPGTFLL | X | A*02:01 (22 nM) | ||||
| DSFPMEIRQY | X | X | No binding predicted | ||||
| DSFPMEIRQYL | X | No binding predicted | |||||
| EVVHKIIEL | X | A*26:01 (211 nM) | |||||
| KLQELNYNL | X | X | X | A*02:01 (6 nM) | |||
| QQLDSKFLEQV | X | X | A*02:01 (176 nM) | ||||
| VLWDRTFSL | X | X | X | X | A*02:01 (3 nM) | ||
| VMLDKQKEL | X | A*02:01 (201 nM) | |||||
| SUGT1 (suppressor of G2 allele of SKP1 homolog) | ETFTEGQKL | X | No binding predicted | ||||
| TOP2A (DNA topoisomerase 2-alpha) | KLAEAERVGLHK | X | A*03:01 (59 nM) | ||||
| KLDETGNSL | X | X | X | A*02:01 (68 nM) | |||
| KLDETGNSLK | X | A*03:01 (153 nM) | |||||
| KLDETGNSLKV | X | A*02:01 (29 nM) | |||||
| SLDKDIVAL | X | A*02:01 (59 nM) | |||||
| THFPDETEI | X | B*38:01 (175 nM) | |||||
| AEINNIIKI | X | X | B*40:01 (58 nM) | ||||
| EVTFVPGLY | X | A*26:01 (12 nM) | |||||
| FLYDDNQRV | X | X | X | X | A*02:01 (4 nM) | ||
| KIFDEILVNA | X | A*02:01 (26 nM) | |||||
| LTYNDFINK | X | A*11:01 (8 nM) | |||||
| TP53 (cellular tumor antigen p53) | GLAPPQHLIRV | X | A*02:01 (18 nM) | ||||
| TTK (dual specificity protein kinase TTK) | ESFSGSLGHL | X | No binding predicted | ||||
| TYMS (thymidylate synthase) | NSELSCQ | X | No binding predicted | ||||
| NSELSCQLY | X | A*01:01 (36 nM) | |||||
| YMIAHITGL | X | X | A*02:01 (3 nM) | ||||
| TYR (tyrosinase) | EEYNSHQSL | X | X | B*40:01 (42 nM) | |||
| EVYPEANAPIGHN | X | No binding predicted | |||||
| HTISSDYVIPIGTY | X | A*26:01 (18 nM) | |||||
| KQLPEEKQPLL | X | X | No binding predicted | ||||
| LEEYNSHQSL | X | X | B*40:01 (47 nM) | ||||
| LLMEKEDYHSL | X | X | X | X | X | A*02:01 (6 nM) | |
| MEKEDYHSL | X | B*40:01 (69 nM) | |||||
| NIFDLSAPEKDKFFA | X | A*02:01 (71 nM) | |||||
| SSDYVIPIGTY | X | A*01:01 (23 nM) | |||||
| YVIPIGTYGQM | X | A*26:01 (37 nM) | |||||
| WNK2 (serine/threonine protein kinase WNK2) | HTRTPPIIHR | X | No binding predicted |